Showing 1 - 20 results of 23 for search 'Fred R. Hirsch', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
Real‐World longitudinal practice patterns in the use of PD‐1 and PD‐L1 inhibitors as First‐Line therapy in patients with Non‐Small cell lung cancer in the United States by Rajwanth Veluswamy, Fred R. Hirsch, Emanuela Taioli, Juan Wisnivesky, Ross Strauss, Douglas Harrough, Boxiong Tang, Gisoo Barnes
Published 2022-11-01
Article -
5
-
6
Radiotherapy and Immunotherapy in Lung Cancer by Kristin Hsieh, Daniel R. Dickstein, Juliana Runnels, Eric J. Lehrer, Kenneth Rosenzweig, Fred R. Hirsch, Robert M. Samstein
Published 2023-06-01
Article -
7
Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer by Anna Solta, Büsra Ernhofer, Kristiina Boettiger, Zsolt Megyesfalvi, Simon Heeke, Mir Alireza Hoda, Christian Lang, Clemens Aigner, Fred R. Hirsch, Karin Schelch, Balazs Döme
Published 2024-02-01
Article -
8
-
9
Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer by Mengting Zhou, Jun Fan, Zhenyu Li, Pindong Li, Yajie Sun, Yuhui Yang, Xiaoshu Zhou, Jing Wang, Ye Wang, Huiwei Qi, Weijing Cai, Xiaofang Dai, Fred R. Hirsch
Published 2019-11-01
Article -
10
Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer by David Dora, Christopher Rivard, Hui Yu, Shivaun Lueke Pickard, Viktoria Laszlo, Tunde Harko, Zsolt Megyesfalvi, Elek Dinya, Csongor Gerdan, Gabor Szegvari, Fred R. Hirsch, Balazs Dome, Zoltan Lohinai
Published 2021-06-01
Article -
11
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution by David Dora, Christopher Rivard, Hui Yu, Paul Bunn, Kenichi Suda, Shengxiang Ren, Shivaun Lueke Pickard, Viktoria Laszlo, Tunde Harko, Zsolt Megyesfalvi, Judit Moldvay, Fred R. Hirsch, Balazs Dome, Zoltan Lohinai
Published 2020-09-01
Article -
12
Early detection of lung cancer by using an autoantibody panel in Chinese population by Shengxiang Ren, Shucai Zhang, Tao Jiang, Yayi He, Zhiyong Ma, Hourong Cai, Xiaohong Xu, Yan Li, Weijing Cai, Jing Zhou, Xiaopeng Liu, Xuejun Hu, Jun Zhang, Hui Yu, Caicun Zhou, Fred R. Hirsch
Published 2018-02-01
Article -
13
Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. by Pierre P Massion, Yong Zou, Hasmet Uner, Porntip Kiatsimkul, Holly J Wolf, Anna E Baron, Tim Byers, Steinn Jonsson, Stephen Lam, Fred R Hirsch, York E Miller, Wilbur A Franklin, Marileila Varella-Garcia
Published 2009-06-01
Article -
14
A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers by Kristin L. Ayers, Meng Ma, Gaspard Debussche, David Corrigan, Jonathan McCafferty, Kyeryoung Lee, Scott Newman, Xiang Zhou, Fred R. Hirsch, Philip C. Mack, Jane J. Liu, Eric E. Schadt, Rong Chen, Shuyu D. Li
Published 2021-04-01
Article -
15
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC by Diego de Miguel‑Perez, Murat Ak, Priyadarshini Mamindla, Alessandro Russo, Serafettin Zenkin, Nursima Ak, Vishal Peddagangireddy, Luis Lara‑Mejia, Muthukumar Gunasekaran, Andres F. Cardona, Aung Naing, Fred R. Hirsch, Oscar Arrieta, Rivka R. Colen, Christian Rolfo
Published 2024-03-01
Article -
16
Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma by Linshan Xie, Hui Kong, Jinjie Yu, Mengting Sun, Shaohua Lu, Yong Zhang, Jie Hu, Fang Du, Qiuyu Lian, Hongyi Xin, Jian Zhou, Xiangdong Wang, Charles A. Powell, Fred R. Hirsch, Chunxue Bai, Yuanlin Song, Jun Yin, Dawei Yang
Published 2024-02-01
Article -
17
The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules by Shahram Tahvilian, Joshua D. Kuban, David F. Yankelevitz, Daniel Leventon, Claudia I. Henschke, Jeffrey Zhu, Lara Baden, Rowena Yip, Fred R. Hirsch, Rebecca Reed, Ashley Brown, Allison Muldoon, Michael Trejo, Benjamin A. Katchman, Michael J. Donovan, Paul C. Pagano
Published 2023-06-01
Article -
18
Expert consensus on the evaluation and management of high-risk indeterminate pulmonary nodules by Yang Dawei, Stephan Lam, Kai Wang, Zhou Jian, Zhang Xiaoju, Wang Qi, Zhou Chengzhi, Zhang Lichuan, Bai Li, Wang Yuehong, Li Ming, Sun Jiayuan, Li Yang, Fengming Kong, Haiquan Chen, Ming Fan, Xuan Jianwei, Fred R. Hirsch, Charles A. Powell, Bai Chunxue
Published 2024-02-01
Article -
19
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400... by Roy S Herbst, Naiyer Rizvi, Karen Kelly, Vassiliki A Papadimitrakopoulou, Natasha B Leighl, Mary W Redman, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, James L Wade, William J Irvin, Sreekanth C Reddy, Jeffrey Crawford, Jeffrey D Bradley, Thomas E Stinchcombe, Suresh S Ramalingam, Jieling Miao, Katherine Minichiello, David R Gandara
Published 2021-08-01
Article -
20
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma by Raffit Hassan, Patrick M Forde, Edward B Garon, Steven M Dubinett, Roy S Herbst, Charu Aggarwal, Matthew D Hellmann, Sarah B Goldberg, David L Rimm, Sarah Sagorsky, Boris Sepesi, Ramaswamy Govindan, Andrea Ferris, Scott J Antonia, Fred R Hirsch, Lawrence H Schwartz, Marianne Davies, Melissa L Johnson, Shakun Malik, Daniel Morgensztern, Joel W Neal, Jyoti D Patel
Published 2022-05-01
Article